Eli Lilly has announced a $3bn expansion to the US manufacturing facility that it acquired from Nexus Pharmaceuticals earlier ...

Sanofi has presented promising results from a phase 3 study of its investigational oral Bruton’s tyrosine kinase (BTK) ...

Of the patients in the poze-cemdi group, 93% achieved LDH normalisation across study visits on average, compared to 65% of ...

Johnson & Johnson (J&J) has shared positive data from a late-stage study of its subcutaneous CD38-directed antibody Darzalex ...

GSK and Rgenta Therapeutics have partnered to develop RNA-targeting small molecule splice modulators for disease areas ...

From animation and gamification, to events, influencers, opinion leaders, and chatbots; there are tools and tactics which can ...

Sanofi has announced plans to invest approximately €1bn to build a new insulin production base in China.

Austin Lee Resourcing was founded with a clear sense of purpose to provide a high level service that is efficient, genuine and innovative to both our candidates and our clients. Our objective is to ...

Novartis will be gaining exclusive global rights to PTC Therapeutics’ mid-stage Huntington’s disease (HD) programme in a deal ...

The National Institute for Health and Care Excellence (NICE) has recommended Santhera Pharmaceuticals’ Agamree (vamorolone) to treat Duchenne muscular dystrophy (DMD). The drug has been recommended ...

Roche has shared new long-term results from a phase 3 study of its anti-CD79b antibody-drug conjugate Polivy (polatuzumab ...

Amgen has announced a $1bn investment to establish a second US drug substance manufacturing facility in North Carolina. The ...